VitaDAO provides $50,000 funding for ImmuneAGE Bio to accelerate its immune rejuvenation research
Longevity Technology - 10-May-2023Will use its drug discovery platform to further development of lead compound, IA101
ImmuneAGE Bio
Drug discovery platform for immune system rejuvenation (in stealth mode)
ImmuneAGE Bio, previously ImmuneAGE Pharma, is a biotech company focusing on immunosensence. The company plans to develop small molecules for immune rejuvenation.
Details last updated 11-May-2023
ImmuneAGE Bio is also referenced in the following:
Translating Rejuvenation of the Immune System - Sebastian Brunemeier at Longevity Summit Dublin 2024
Sebastian Brunemeier delivered a keynote on translating the rejuvenation of the immune system
ImmuneAGE Bio News
